ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis

Lioba Koerner,Laurens Wachsmuth,Snehlata Kumari,Robin Schwarzer,Theresa Wagner,Huipeng Jiao,Manolis Pasparakis

DOI: https://doi.org/10.1038/s41418-024-01321-6

IF: 12.067

2024-06-08

Cell Death and Differentiation

Abstract:Z-DNA binding protein 1 (ZBP1) has important functions in anti-viral immunity and in the regulation of inflammatory responses. ZBP1 induces necroptosis by directly engaging and activating RIPK3, however, the mechanisms by which ZBP1 induces inflammation and in particular the role of RIPK1 and the contribution of cell death-independent signaling remain elusive. Here we show that ZBP1 causes skin inflammation by inducing RIPK3-mediated necroptosis and RIPK1-caspase-8-mediated apoptosis in keratinocytes. ZBP1 induced TNFR1-independent skin inflammation in mice with epidermis-specific ablation of FADD by triggering keratinocyte necroptosis. Moreover, transgenic expression of C-terminally truncated constitutively active ZBP1 (ZBP1ca) in mouse epidermis caused skin inflammation that was only partially inhibited by abrogation of RIPK3-MLKL-dependent necroptosis and fully prevented by combined deficiency in MLKL and caspase-8. Importantly, ZBP1ca induced caspase-8-mediated skin inflammation by RHIM-dependent but kinase activity-independent RIPK1 signaling. Furthermore, ZBP1ca-induced inflammatory cytokine production in the skin was completely prevented by combined inhibition of apoptosis and necroptosis arguing against a cell death-independent pro-inflammatory function of ZBP1. Collectively, these results showed that ZBP1 induces inflammation by activating necroptosis and RIPK1 kinase activity-independent apoptosis.

cell biology,biochemistry & molecular biology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **How does ZBP1 (Z - DNA - binding protein 1) induce an inflammatory response in vivo, especially whether it functions through RIPK1 - mediated cell death and inflammatory pathology?** Specifically, the researchers are concerned with: 1. **How does ZBP1 trigger TNFR1 - independent skin inflammation in keratinocytes lacking FADD (Fas - associated death domain)?** Previous studies have shown that FADD deficiency leads to necroptosis in keratinocytes and causes skin inflammation, but TNFR1 deficiency can only partially relieve this inflammation. 2. **Can ZBP1 activate RIPK3 - MLKL - dependent necroptosis through its RHIM domain and also induce caspase - 8 - mediated apoptosis independent of RIPK1 kinase activity?** This will help to understand the dual - role mechanism of ZBP1 in cell death and inflammation. To verify these hypotheses, the researchers used multiple genetic mouse models, including genetically engineered mice with specific knockout of FADD, TNFR1 or ZBP1, and studied the role of ZBP1 in keratinocytes by transgenic expression of a truncated form of ZBP1 (ZBP1ca). The experimental results show that ZBP1 can indeed induce inflammation through the above pathways. In particular, in the absence of FADD, ZBP1 synergizes with TNFR1 to drive necroptosis in keratinocytes and skin inflammation. In addition, the study also found that ZBP1ca expression can cause cell death in keratinocytes, which in turn leads to skin inflammation. This process depends on ZBP1's ability to sense ligands and its interaction with RIPK1 and RIPK3, and does not involve cell - death - independent NF - κB signaling. In summary, this study reveals the key role of ZBP1 in the inflammatory response and its specific molecular mechanism, providing new insights into understanding the function of ZBP1 in the immune response and disease development.

ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1

Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation

NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation

Z-DNA binding protein 1 orchestrates innate immunity and inflammatory cell death

A shorter splicing isoform antagonizes ZBP1 to modulate cell death and inflammatory responses

A ZBP1 isoform blocks ZBP1-mediated cell death

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

ZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1

RIP1 kinase activity is critical for skin inflammation but not for viral propagation

ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice

ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1

Z-nucleic acid sensor ZBP1 in sterile inflammation

The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation

Regulation of Zfp36 by ISGF3 and MK2 restricts the expression of inflammatory cytokines during necroptosis stimulation

ZBP1-Mediated Necroptosis: Mechanisms and Therapeutic Implications

RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis

RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation

RIPK1 is essential for Herpes Simplex Virus-triggered ZBP1-dependent necroptosis in human cells

A Novel Zinc Finger Protein Interacts with Receptor-interacting Protein (RIP) and Inhibits Tumor Necrosis Factor (TNF)- and IL1-induced NF-κB Activation

Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response